Aerovate Therapeutics, Inc. Short Interest Down 5.3 percent in November - MarketBeat
AVTE Stock | USD 2.53 0.03 1.17% |
About 69% of Aerovate Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Aerovate Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Aerovate Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Aerovate Therapeutics stock news signals to limit their universe of possible portfolio assets.
Aerovate |
Aerovate Therapeutics, Inc. Short Interest Down 5.3 percent in November MarketBeat
Read at news.google.com
Aerovate Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Aerovate Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aerovate Therapeutics Fundamental Analysis
We analyze Aerovate Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aerovate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aerovate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Aerovate Therapeutics is currently under evaluation in target price category among its peers.
Aerovate Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aerovate Therapeutics stock to make a market-neutral strategy. Peer analysis of Aerovate Therapeutics could also be used in its relative valuation, which is a method of valuing Aerovate Therapeutics by comparing valuation metrics with similar companies.
Peers
Aerovate Therapeutics Related Equities
MLYS | Mineralys Therapeutics, | 4.31 | ||||
RZLT | Rezolute | 3.68 | ||||
OPT | Opthea | 3.41 | ||||
ACRV | Acrivon Therapeutics, | 0.30 | ||||
ANTX | AN2 Therapeutics | 0.79 | ||||
ADAG | Adagene | 1.47 | ||||
ANEB | Anebulo Pharmaceuticals | 10.81 |
Complementary Tools for Aerovate Stock analysis
When running Aerovate Therapeutics' price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |